{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:23:50Z","timestamp":1783052630222,"version":"3.54.6"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.clml.2020.02.003","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T17:26:53Z","timestamp":1581528413000},"page":"e368-e374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["RAS Pathway Mutation Patterns in Patients With Juvenile Myelomonocytic Leukemia: A Developing Country Single-center Experience"],"prefix":"10.1016","volume":"20","author":[{"given":"Nayera","family":"Hamdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Bokhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Hozayn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Alsheshtawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanafy","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1677-0360","authenticated-orcid":false,"given":"Mahmoud","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.02.003_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood.V90.2.479","article-title":"Juvenile myelomonocytic leukemia","volume":"90","author":"Aric\u00f2","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.003_bib2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2141.2007.06958.x","article-title":"Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment option","volume":"140","author":"Niemeyer","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.02.003_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2141.2010.08525.x","article-title":"Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia","volume":"152","author":"Loh","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.02.003_bib4","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1182\/blood-2017-07-798157","article-title":"Integrated molecular profiling of juvenile myelomonocytic leukemia","volume":"131","author":"Murakami","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.003_bib5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.exphem.2008.04.016","article-title":"Activating PTPN11 mutants promote hematopoietic progenitor cell-cycle progression and survival","volume":"36","author":"Yang","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.clml.2020.02.003_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clml.2020.02.003_bib7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nrm1762","article-title":"The Cbl interactome and its functions","volume":"6","author":"Schmidt","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.clml.2020.02.003_bib8","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.003_bib9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity","volume":"70","author":"Marco","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clml.2020.02.003_bib10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00277-011-1326-9","article-title":"Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia","volume":"91","author":"Park","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.02.003_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2407-9-179","article-title":"Fast simultaneous detection of K-RAS mutations in colorectal cancer","volume":"9","author":"Chang","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2020.02.003_bib12","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood-2009-01-198416","article-title":"Mutations in CBL occur frequently in juvenile myelomonocytic leukemia","volume":"114","author":"Loh","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.003_bib13","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2005-02-0531","article-title":"The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myeloproliferative disease","volume":"106","author":"Kratz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.003_bib14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.2698","article-title":"Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia","volume":"45","author":"Sakaguchi","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.clml.2020.02.003_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3324\/haematol.2009.016865","article-title":"Molecular basis of juvenile myelomonocytic leukemia","volume":"95","author":"de Vries","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.02.003_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2141.2010.08196.x","article-title":"Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations","volume":"150","author":"Yuka","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.02.003_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.leu.2401240","article-title":"RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)","volume":"13","author":"Flotho","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.02.003_bib18","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/blood.V84.10.3435.3435","article-title":"Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras","volume":"84","author":"Kalra","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.003_bib19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2141.2010.08393.x","article-title":"Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia","volume":"151","author":"P\u00e9rez","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.02.003_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1203\/PDR.0b013e3181961d2a","article-title":"Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia","volume":"65","author":"Yoshida","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clml.2020.02.003_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.clml.2020.02.003_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/BJ20050892","article-title":"c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses","volume":"391","author":"Thien","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.clml.2020.02.003_bib23","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1182\/blood-2007-01-066076","article-title":"Flt3-dependent transformation by inactivating c-Cbl mutations in AML","volume":"110","author":"Sargin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.003_bib24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2141.2008.07104.x","article-title":"Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia","volume":"141","author":"Koike","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.02.003_bib25","first-page":"3534","article-title":"Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)","volume":"89","author":"Niemeyer","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.003_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/1097-0142(1984)54:4<675::AID-CNCR2820540415>3.0.CO;2-Q","article-title":"Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors","volume":"54","author":"Castro-Malaspina","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.02.003_bib27","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/bjc.1994.431","article-title":"Neurofibromatosis and childhood leukaemia\/lymphoma: a population-based UKCCSG study","volume":"70","author":"Stiller","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clml.2020.02.003_bib28","first-page":"345","article-title":"Monosomy-7 in childhood hemopoietic disorder","volume":"4","author":"Baranger","year":"1990","journal-title":"Leukemia"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020300689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020300689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:35:07Z","timestamp":1761870907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020300689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2152265020300689"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.02.003","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAS Pathway Mutation Patterns in Patients With Juvenile Myelomonocytic Leukemia: A Developing Country Single-center Experience","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}